Tag: genomics
NVIDIA and Harvard researchers use AI to make genome analysis faster and cheaper
Scientists from NVIDIA and Harvard have made a huge breakthrough in genetic research. They developed a deep-learning toolkit that is able to significantly cut down the time and cost needed to run rare and single-cell experiments. According to a study… Source
Read More
DeepMind’s latest AI breakthrough can accurately predict the way proteins fold
Alphabet-owned DeepMind may be best known for building the AI that beat a world-class Go player, but the company announced another, perhaps more vital breakthrough this morning. As part of its work for the 14th Critical Assessment of Protein Structur… Source
Read More
Tia Health gets over $24 million to build a network of holistic health clinics and virtual services for women
Tia Health, the developer of a network of digital wellness apps, clinics and telehealth services designed to treat women’s health holistically, has raised $24.275 million in a new round of funding. The company said that the financing would support the expansion of its telehealth and clinical services to new markets,…
Read More
Africa Roundup: Visa connects to M-Pesa, Flutterwave enters e-commerce
It seems the demand for Safaricom’s M-Pesa payment product never eases. Since its 2007 launch in Kenya, the fintech app has commanded over 70% of the mobile money market in that country. When COVID-19 hit the East African nation of 53 million in March, the Kenyan Central Bank turned to…
Read More
IBM shares AI tools to better understand and treat COVID-19
IBM wants to help researchers better understand and treat COVID-19. To do so, it’s putting its AI to work. It has released a series of new tools to aggregate data, help researchers explore potential therapies, advance the study of newly sequenced SAR… Source
Read More
Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19
Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and Drug Administration to begin early-stage clinical trials on a potential treatment for COVID-19. The company, which has raised at least $290 million to date (according to Crunchbase), uses “Natural Killer”…
Read More